(Reuters) – AstraZeneca may have provided an incomplete view of efficacy data on its COVID-19 vaccine from a large scale trial in the United States, a U.S. health agency said Tuesday, in a fresh setback for the shot.FILE PHOTO: A man undergoes the coronavirus disease (COVID-19) test at a testing site which is temporarily set […]